Compare EVO & UVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVO | UVE |
|---|---|---|
| Founded | 1993 | 1990 |
| Country | Germany | United States |
| Employees | 4553 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 957.6M |
| IPO Year | N/A | 1996 |
| Metric | EVO | UVE |
|---|---|---|
| Price | $3.07 | $36.91 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $7.00 | ★ $40.00 |
| AVG Volume (30 Days) | 47.1K | ★ 156.4K |
| Earning Date | 04-08-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.97% |
| EPS Growth | N/A | ★ 214.43 |
| EPS | N/A | ★ 1.88 |
| Revenue | N/A | ★ $1,603,915,000.00 |
| Revenue This Year | $1.37 | N/A |
| Revenue Next Year | $10.05 | $2.88 |
| P/E Ratio | ★ N/A | $20.02 |
| Revenue Growth | N/A | ★ 5.48 |
| 52 Week Low | $2.31 | $21.96 |
| 52 Week High | $4.42 | $41.96 |
| Indicator | EVO | UVE |
|---|---|---|
| Relative Strength Index (RSI) | 56.03 | 40.68 |
| Support Level | $2.88 | $32.51 |
| Resistance Level | $3.75 | $41.32 |
| Average True Range (ATR) | 0.07 | 1.16 |
| MACD | 0.01 | -0.45 |
| Stochastic Oscillator | 89.58 | 1.98 |
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.
Universal Insurance Holdings Inc is an insurance holding company. Through its subsidiaries, the company mainly offers property and casualty insurance and value-added insurance services. It develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners lines of business and performs all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The group offers the following types of personal residential insurance: homeowners, renters/tenants, condo unit owners, and dwelling/fire, through an independent agent network and online distribution channels across multiple states in the United States of America.